News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY)'s Neutrophase® Is Best In Class In Laboratory Study Of 19 Top Commercial Wound Cleansers



2/17/2014 8:39:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif., Feb. 17, 2014 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic anti-microbial products, today announced that a new study in the journal Advances in Skin & Wound Care showed that the company's wound cleanser, NeutroPhase®*, achieved better results in lab tests than 18 other commercial products. Unlike any of the other products, NeutroPhase was able to kill bacteria in less than a minute.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES